Elevance Health, Inc.
For the period ended Sep 30, 2025. Filed Oct 21, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 21, 2025
ELV$429.65+2.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income (Unaudited) for the and
Consolidated Statements of Comprehensive Income
| Three Months Ended September 30 | Nine Months Ended September 30 | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| (In millions) | ||||
| Net income | $1,187 | $1,008 | $5,115 | $5,558 |
| Other comprehensive income, net of tax: | ||||
| Change in net unrealized gains on investments | 220 | 887 | 603 | 805 |
| Change in non-credit component of impairment losses on investments | 1 | — | (1) | — |
| Change in net unrealized gains (losses) on net cash flow hedges | (3) | 2 | 5 | 8 |
| Change in net periodic pension and postretirement costs | 4 | 3 | 1 | 11 |
| Change in future policy benefits | (2) | (1) | (1) | (2) |
| Foreign currency translation adjustments | (1) | 7 | 1 | 2 |
| Other comprehensive income | 219 | 898 | 608 | 824 |
| Net loss attributable to noncontrolling interests | 2 | 8 | — | 4 |
| Other comprehensive income attributable to noncontrolling interests | (2) | — | (4) | — |
| Total shareholders’ comprehensive income | $1,406 | $1,914 | $5,719 | $6,386 |
-4-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.